Explore 3 Stock Ideas & Industry Insights Download Free Report
Clinical applications could shape Oxford Nanopore (LSE:ONT) because moving its DNA and RNA sequencing technology from the research bench into hospitals and diagnostics is the company's clearest route to faster growth and, eventually, profit. Clinical work commands higher volumes and more repeatableDemandthan one-off research …
CVS Group PLC (LSE:CVSG) shares fell -0.15% today, based on the supplied market data. The shares last traded at 1316.00p, down -2.00 on the day.
Genus PLC shares fell -1.50% today, based on the supplied market data. The shares last traded at 2102.00p, down -32.00 on the day.
Scancell Holdings, listed on London’s AIM, develops off-the-shelf cancer immunotherapies, often described as therapeutic cancer vaccines, designed to stimulate the immune system to attack tumours. It works across platforms including its DNA-based ImmunoBody technology, behind its lead melanoma candidate iSCIB1+, and its Moditope platform, …
AOTI, listed on London’s AIM, develops and sells topical wound oxygen therapy, marketed as TWO2, an intermittent oxygen treatment delivered to patients at home for chronic wounds such as diabetic foot ulcers. By applying oxygen directly to the wound in cycles, the therapy aims …
Diaceutics, listed on London’s AIM, providesData Analyticsand advisory services to pharmaceutical companies, helping them commercialise precision-medicine therapies. Many modern drugs work only for patients with specific biomarkers, so identifying and testing those patients is essential. Through its DXRX platform, Diaceutics gathers and analyses diagnostic …
Spire Healthcare Group PLC — LSE:SPI closed 0.20% lower on17 September 2026, with the shares at 245.50p after a decline of 0.50p on the day.
Genus PLC — LSE:GNS closed 0.37% higher on17 September 2026, with the shares at 2,158.00p after a gain of 8.00p on the day.
Oxford Nanopore Technologies PLC — LSE:ONT closed 0.59% higher on17 September 2026, with the shares at 162.26p after a gain of 0.96p on the day.
Half-year figures published on 6 August 2026 revealed a group leaning on its other divisions while injectables paused for breath.
We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.
These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.
We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.
These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Download Free Report
Hi! How can we help you today?
Loading…